These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26824954)

  • 21. Global gene expression in Staphylococcus aureus biofilms.
    Beenken KE; Dunman PM; McAleese F; Macapagal D; Murphy E; Projan SJ; Blevins JS; Smeltzer MS
    J Bacteriol; 2004 Jul; 186(14):4665-84. PubMed ID: 15231800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impacts of
    Rom JS; Ramirez AM; Beenken KE; Sahukhal GS; Elasri MO; Smeltzer MS
    Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31740526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin.
    Su J; Iehara M; Yasukawa J; Matsumoto Y; Hamamoto H; Sekimizu K
    J Antibiot (Tokyo); 2015 Oct; 68(10):646-8. PubMed ID: 25899124
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of oleic acid (cis-9-octadecenoic acid) on bacterial viability and biofilm production in Staphylococcus aureus.
    Stenz L; François P; Fischer A; Huyghe A; Tangomo M; Hernandez D; Cassat J; Linder P; Schrenzel J
    FEMS Microbiol Lett; 2008 Oct; 287(2):149-55. PubMed ID: 18754790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation.
    Beenken KE; Mrak LN; Griffin LM; Zielinska AK; Shaw LN; Rice KC; Horswill AR; Bayles KW; Smeltzer MS
    PLoS One; 2010 May; 5(5):e10790. PubMed ID: 20520723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vision for medicine: Staphylococcus aureus biofilm war and unlocking key's for anti-biofilm drug development.
    Mohammed YHE; Manukumar HM; Rakesh KP; Karthik CS; Mallu P; Qin HL
    Microb Pathog; 2018 Oct; 123():339-347. PubMed ID: 30057355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
    Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
    BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
    Velazquez A; DeRyke CA; Goering R; Hoover V; Wallace MR
    Clin Microbiol Infect; 2013 Dec; 19(12):1169-72. PubMed ID: 23480569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of Staphylococcus aureus Catheter-Related Biofilm Infections Using ML:8 and Citrox.
    Hogan S; Zapotoczna M; Stevens NT; Humphreys H; O'Gara JP; O'Neill E
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5968-75. PubMed ID: 27458213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biofilm and Small Colony Variants-An Update on
    Guo H; Tong Y; Cheng J; Abbas Z; Li Z; Wang J; Zhou Y; Si D; Zhang R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro Activity of Linezolid, Daptomycin and N-acetylcysteine Agents on Staphylococcus Aureus Biofilms in the Ventriculoperitoneal Shunt Model.
    Kuruoglu T; Onger ME; Turan DB; Kuruoglu E
    Turk Neurosurg; 2019; 29(1):66-71. PubMed ID: 29582407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of extracellular nuclease production on the biofilm phenotype of Staphylococcus aureus under in vitro and in vivo conditions.
    Beenken KE; Spencer H; Griffin LM; Smeltzer MS
    Infect Immun; 2012 May; 80(5):1634-8. PubMed ID: 22354028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic implications of
    Vila T; Kong EF; Montelongo-Jauregui D; Van Dijck P; Shetty AC; McCracken C; Bruno VM; Jabra-Rizk MA
    Virulence; 2021 Dec; 12(1):835-851. PubMed ID: 33682623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of sigB mutation on Staphylococcus aureus oxacillin and vancomycin resistance varies with parental background and method of assessment.
    Singh VK; Schmidt JL; Jayaswal RK; Wilkinson BJ
    Int J Antimicrob Agents; 2003 Mar; 21(3):256-61. PubMed ID: 12636988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.
    Hogan S; O'Gara JP; O'Neill E
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants.
    Loughran AJ; Atwood DN; Anthony AC; Harik NS; Spencer HJ; Beenken KE; Smeltzer MS
    Microbiologyopen; 2014 Dec; 3(6):897-909. PubMed ID: 25257373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin.
    Mirani ZA; Aziz M; Khan MN; Lal I; Hassan NU; Khan SI
    Microb Pathog; 2013; 61-62():66-72. PubMed ID: 23711963
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Shukla SK; Rao TS
    Indian J Med Res; 2017 Jul; 146(Supplement):S1-S8. PubMed ID: 29205189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended biofilm susceptibility assay for Staphylococcus aureus bovine mastitis isolates: evidence for association between genetic makeup and biofilm susceptibility.
    Melchior MB; van Osch MH; Lam TJ; Vernooij JC; Gaastra W; Fink-Gremmels J
    J Dairy Sci; 2011 Dec; 94(12):5926-37. PubMed ID: 22118083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.